Search

everythinglearnresearchcommunity

for

Search:↓

A 4-year-old girl was diagnosed with erythrokeratodermia variabilis after other treatments failed.

Premature graying of hair significantly harms psychological and social wellbeing.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Herbal treatments can help manage PCOS symptoms.

Oxidative stress is linked to mild patchy alopecia areata.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

Pregnancies in a woman with the Donohue mutation were managed with genetic testing, resulting in three healthy infants.

Mast cells and VEGF contribute to post-surgery adhesions, and blocking VEGF can reduce these adhesions; also, certain factors affect wound healing and fetal skin heals differently with age.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Diagnosing and treating skin conditions is challenging, especially when drug reactions mimic other diseases.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride safely lowers DHT levels without affecting testosterone.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Condensed nanofat with fat grafts effectively improves atrophic facial scars.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.